| __timestamp | Supernus Pharmaceuticals, Inc. | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 72471000 | 305409000 |
| Thursday, January 1, 2015 | 89204000 | 377080000 |
| Friday, January 1, 2016 | 106010000 | 432829000 |
| Sunday, January 1, 2017 | 137905000 | 496079000 |
| Monday, January 1, 2018 | 159888000 | 557616000 |
| Tuesday, January 1, 2019 | 158425000 | 658498000 |
| Wednesday, January 1, 2020 | 200677000 | 770456000 |
| Friday, January 1, 2021 | 304759000 | 840100000 |
| Saturday, January 1, 2022 | 377221000 | 944700000 |
| Sunday, January 1, 2023 | 336361000 | 1136600000 |
| Monday, January 1, 2024 | 1464300000 |
Unveiling the hidden dimensions of data
In the competitive landscape of pharmaceuticals, effective cost management is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Vertex Pharmaceuticals Incorporated and Supernus Pharmaceuticals, Inc. over the past decade. From 2014 to 2023, Vertex Pharmaceuticals saw a significant increase in SG&A expenses, rising by approximately 272%, from around 305 million to over 1.1 billion. This growth reflects their aggressive expansion and investment in administrative capabilities. Meanwhile, Supernus Pharmaceuticals experienced a more moderate increase of about 364%, from 72 million to 336 million, indicating a steady scaling of operations.
These trends highlight the strategic financial decisions made by both companies in response to market demands and growth opportunities.
Selling, General, and Administrative Costs: Novartis AG vs Supernus Pharmaceuticals, Inc.
Selling, General, and Administrative Costs: Pfizer Inc. vs Vertex Pharmaceuticals Incorporated
Breaking Down SG&A Expenses: Vertex Pharmaceuticals Incorporated vs Zoetis Inc.
Vertex Pharmaceuticals Incorporated and Teva Pharmaceutical Industries Limited: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Vertex Pharmaceuticals Incorporated or Exelixis, Inc.
Operational Costs Compared: SG&A Analysis of Vertex Pharmaceuticals Incorporated and Opthea Limited
Cost Management Insights: SG&A Expenses for Vertex Pharmaceuticals Incorporated and Ultragenyx Pharmaceutical Inc.
Vertex Pharmaceuticals Incorporated and Amneal Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Cost of Revenue Comparison: Vertex Pharmaceuticals Incorporated vs Supernus Pharmaceuticals, Inc.
Selling, General, and Administrative Costs: Vertex Pharmaceuticals Incorporated vs Viridian Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Biogen Inc. or Supernus Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Verona Pharma plc or Supernus Pharmaceuticals, Inc.